Cargando…

Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report

Ocular myasthenia gravis (OMG) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. We describe a 16-year-old female who presented to our clinic with 1-month complaints of diplopia and strabismus, visual acuity deterioration, and ocular irritatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnon, Roee, Yahalomi, Tal, Rozen-Knisbacher, Irit, Pikkel, Joseph, Mostovoy, Dina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443649/
https://www.ncbi.nlm.nih.gov/pubmed/32884545
http://dx.doi.org/10.1159/000508815
_version_ 1783573667362373632
author Arnon, Roee
Yahalomi, Tal
Rozen-Knisbacher, Irit
Pikkel, Joseph
Mostovoy, Dina
author_facet Arnon, Roee
Yahalomi, Tal
Rozen-Knisbacher, Irit
Pikkel, Joseph
Mostovoy, Dina
author_sort Arnon, Roee
collection PubMed
description Ocular myasthenia gravis (OMG) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. We describe a 16-year-old female who presented to our clinic with 1-month complaints of diplopia and strabismus, visual acuity deterioration, and ocular irritation. Her examination showed crossed diplopia and alternating exotropia of 25 prism diopters, severe blepharitis, conjunctival hyperemia, corneal pannus, epithelial irregularities, and subepithelial opacities. Workup included pediatric neurologic examination, laboratory tests, imaging, and electrophysiological tests. Diagnoses of OMG and blepharitis with ocular surface disease were made. Topical treatment included eyelid hygiene, tea tree oil scrubbing, topical steroids, and tacrolimus ointment. Systemic treatment included corticosteroids, pyridostigmine, azathioprine, intravenous immunoglobulins, amitriptyline, and doxycycline. Both diseases were refractory to intensive immunosuppressive treatment and had simultaneous relapses and an intertwined course. Our hypothesis is that a shared immune mechanism may be the cause of both OMG and ocular surface disease in our patient.
format Online
Article
Text
id pubmed-7443649
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-74436492020-09-02 Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report Arnon, Roee Yahalomi, Tal Rozen-Knisbacher, Irit Pikkel, Joseph Mostovoy, Dina Case Rep Ophthalmol Case Report Ocular myasthenia gravis (OMG) is an autoimmune disease of the neuromuscular junction and commonly associated with other immune diseases. We describe a 16-year-old female who presented to our clinic with 1-month complaints of diplopia and strabismus, visual acuity deterioration, and ocular irritation. Her examination showed crossed diplopia and alternating exotropia of 25 prism diopters, severe blepharitis, conjunctival hyperemia, corneal pannus, epithelial irregularities, and subepithelial opacities. Workup included pediatric neurologic examination, laboratory tests, imaging, and electrophysiological tests. Diagnoses of OMG and blepharitis with ocular surface disease were made. Topical treatment included eyelid hygiene, tea tree oil scrubbing, topical steroids, and tacrolimus ointment. Systemic treatment included corticosteroids, pyridostigmine, azathioprine, intravenous immunoglobulins, amitriptyline, and doxycycline. Both diseases were refractory to intensive immunosuppressive treatment and had simultaneous relapses and an intertwined course. Our hypothesis is that a shared immune mechanism may be the cause of both OMG and ocular surface disease in our patient. S. Karger AG 2020-07-13 /pmc/articles/PMC7443649/ /pubmed/32884545 http://dx.doi.org/10.1159/000508815 Text en Copyright © 2020 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission.
spellingShingle Case Report
Arnon, Roee
Yahalomi, Tal
Rozen-Knisbacher, Irit
Pikkel, Joseph
Mostovoy, Dina
Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report
title Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report
title_full Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report
title_fullStr Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report
title_full_unstemmed Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report
title_short Ocular Myasthenia Gravis with Severe Blepharitis and Ocular Surface Disease: A Case Report
title_sort ocular myasthenia gravis with severe blepharitis and ocular surface disease: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443649/
https://www.ncbi.nlm.nih.gov/pubmed/32884545
http://dx.doi.org/10.1159/000508815
work_keys_str_mv AT arnonroee ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport
AT yahalomital ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport
AT rozenknisbacheririt ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport
AT pikkeljoseph ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport
AT mostovoydina ocularmyastheniagraviswithsevereblepharitisandocularsurfacediseaseacasereport